NO173556C - Monoklonalt antistoff som gjenkjenner alpha-2-3-bindinger, og hybridomcellelinje som produserer antistoffet - Google Patents

Monoklonalt antistoff som gjenkjenner alpha-2-3-bindinger, og hybridomcellelinje som produserer antistoffet

Info

Publication number
NO173556C
NO173556C NO885113A NO885113A NO173556C NO 173556 C NO173556 C NO 173556C NO 885113 A NO885113 A NO 885113A NO 885113 A NO885113 A NO 885113A NO 173556 C NO173556 C NO 173556C
Authority
NO
Norway
Prior art keywords
monoclonal antibody
binding
alpha
cell line
antibody
Prior art date
Application number
NO885113A
Other languages
English (en)
Norwegian (no)
Other versions
NO885113D0 (no
NO885113L (no
NO173556B (no
Inventor
Yoshitaka Nagai
Hideki Yamamoto
Kinji Takada
Masayoshi Ito
Yoshiyasu Shitori
Original Assignee
Kanto Ishi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanto Ishi Pharma Co Ltd filed Critical Kanto Ishi Pharma Co Ltd
Publication of NO885113D0 publication Critical patent/NO885113D0/no
Publication of NO885113L publication Critical patent/NO885113L/no
Publication of NO173556B publication Critical patent/NO173556B/no
Publication of NO173556C publication Critical patent/NO173556C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57469—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving tumor associated glycolinkage, i.e. TAG
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/806—Drug, bio-affecting and body treating compositions involving IgM
    • Y10S424/807—Monoclonal
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
    • Y10S530/864—Monoclonal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NO885113A 1987-11-17 1988-11-16 Monoklonalt antistoff som gjenkjenner alpha-2-3-bindinger, og hybridomcellelinje som produserer antistoffet NO173556C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62290310A JP2754206B2 (ja) 1987-11-17 1987-11-17 α２→３結合を認識するモノクローナル抗体

Publications (4)

Publication Number Publication Date
NO885113D0 NO885113D0 (no) 1988-11-16
NO885113L NO885113L (no) 1989-05-18
NO173556B NO173556B (no) 1993-09-20
NO173556C true NO173556C (no) 1993-12-29

Family

ID=17754449

Family Applications (1)

Application Number Title Priority Date Filing Date
NO885113A NO173556C (no) 1987-11-17 1988-11-16 Monoklonalt antistoff som gjenkjenner alpha-2-3-bindinger, og hybridomcellelinje som produserer antistoffet

Country Status (14)

Country Link
US (1) US5141864A (de)
EP (1) EP0316882B1 (de)
JP (1) JP2754206B2 (de)
KR (1) KR960014441B1 (de)
CN (1) CN1042734A (de)
AT (1) ATE108482T1 (de)
AU (1) AU624583B2 (de)
CA (1) CA1337800C (de)
DE (1) DE3850634T2 (de)
FI (1) FI95043C (de)
HU (1) HU204573B (de)
IL (1) IL88400A (de)
NO (1) NO173556C (de)
NZ (1) NZ226974A (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4107154A1 (de) * 1990-10-11 1992-04-16 Boehringer Mannheim Gmbh Monoklonale antikoerper gegen melanom
DE4208795A1 (de) * 1992-03-19 1993-09-23 Behringwerke Ag Monoklonaler anti-gangliosid-antikoerper, seine herstellung und verwendung als tumortherapeutikum
CN1057128C (zh) * 1993-09-22 2000-10-04 南通医学院 感觉神经抗体及其制备方法
US5674681A (en) 1994-12-06 1997-10-07 Rothenberg; Barry E. Methods to identify hemochromatosis
CU23007A1 (es) * 2001-04-06 2004-12-17 Ct De Inmunologia Molecular Ct De Inmunologia Mole Combinaciones inmunoterapéuticas para el tratamiencombinaciones inmunoterapéuticas para el tratamiento de tumores que sobre-expresan gangliósidos to de tumores que sobre-expresan gangliósidos
WO2004087911A1 (ja) * 2003-03-28 2004-10-14 Toyama New Industry Organization １個の抗原特異的ｂリンパ球を用いた抗原特異的抗体産生ハイブリドーマの作製方法及びモノクローナル抗体の製造方法
FI20070199A0 (fi) * 2007-03-08 2007-03-08 Glykos Finland Oy Uusia happamia N-glykaanirakenteita
EP2606897A1 (de) 2011-12-22 2013-06-26 Laboratorios Del. Dr. Esteve, S.A. Verfahren und Zusammensetzungen für die Behandlung von Krankheiten, die von eingehüllten Viren verursacht werden

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507391A (en) * 1982-04-02 1985-03-26 Sloan-Kettering Institute For Cancer Research Method for detecting the presence of GD3 ganglioside

Also Published As

Publication number Publication date
EP0316882A2 (de) 1989-05-24
NO885113D0 (no) 1988-11-16
AU624583B2 (en) 1992-06-18
US5141864A (en) 1992-08-25
CN1042734A (zh) 1990-06-06
AU2518688A (en) 1989-05-25
HU204573B (en) 1992-01-28
ATE108482T1 (de) 1994-07-15
FI95043B (fi) 1995-08-31
NZ226974A (en) 1990-03-27
IL88400A0 (en) 1989-06-30
KR890008320A (ko) 1989-07-10
DE3850634T2 (de) 1994-10-27
KR960014441B1 (ko) 1996-10-15
FI885279A0 (fi) 1988-11-15
IL88400A (en) 1993-06-10
EP0316882A3 (en) 1990-03-14
JP2754206B2 (ja) 1998-05-20
CA1337800C (en) 1995-12-26
FI885279A (fi) 1989-05-18
EP0316882B1 (de) 1994-07-13
NO885113L (no) 1989-05-18
FI95043C (fi) 1995-12-11
NO173556B (no) 1993-09-20
DE3850634D1 (de) 1994-08-18
JPH01132374A (ja) 1989-05-24
HUT48679A (en) 1989-06-28

Similar Documents

Publication Publication Date Title
PT86792A (pt) Monoclonal antibodies against melanoma-associated antigens hybrid cell lines producing these antibodies and use therefor
DK609985A (da) Adhesin-antigener, antistoffer mod disse og dna-fragmenter, som indkoder antigenerne
FR14C0070I1 (fr) Procede de la production des anticorps humanises
IL61876A0 (en) Monoclonal antibody to a human t cell antigen,its production and compositions containing it
YU45068B (en) Process for obtaining a monoclonal antibody which is fixing a complement
NO173556C (no) Monoklonalt antistoff som gjenkjenner alpha-2-3-bindinger, og hybridomcellelinje som produserer antistoffet
DK392387A (da) Monoklonalt antistrof til diagnostisk anvendelse og fremgangsmaade til fremstilling af et saadan antistof
SE8103198L (sv) Forfarande for framstellning av antikroppar
GR3007698T3 (de)
NO174855C (no) Monoklonalt antistoff og cellelinje som produserer dette
DK227184D0 (da) Agarfibre indeholdende deri immobiliserede enzymholdige mikroorganismeceller og fremgangsmaade til fremstilling deraf
FI873233A (fi) Modifierade virala glykoproteiner.
NO174632C (no) Monoklonale antistoffer som er i stand til å gjenkjenne gangliosider GQ1B og GT1A og en hyberidom som produserer disse antistoffene